• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

嗜酸性粒细胞增多与喘息：突破哮喘的思维局限

Eosinophilia and wheeze: thinking beyond asthma.

作者信息

Kuek Stephanie L, Pettman Colin, Neeland Melanie R, Harrison Joanne, Mehr Sam, Shanthikumar Shivanthan, Beggs Sean

机构信息

Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Australia.

Department of Paediatrics, University of Melbourne, Melbourne, Australia.

出版信息

Breathe (Sheff). 2024 Mar;20(1):230126. doi: 10.1183/20734735.0126-2023. Epub 2024 Mar 12.

DOI:10.1183/20734735.0126-2023
PMID:38482189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10928552/
Abstract

https://bit.ly/4bgDP1u.

摘要

https://bit.ly/4bgDP1u. （链接内容无法翻译，仅保留原链接）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/3bcb4e4b517f/EDU-0126-2023.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/6ae763eacd1c/EDU-0126-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/a1b40b63587c/EDU-0126-2023.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/3bcb4e4b517f/EDU-0126-2023.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/6ae763eacd1c/EDU-0126-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/a1b40b63587c/EDU-0126-2023.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e21/10928552/3bcb4e4b517f/EDU-0126-2023.03.jpg

相似文献

1
Eosinophilia and wheeze: thinking beyond asthma.嗜酸性粒细胞增多与喘息：突破哮喘的思维局限
Breathe (Sheff). 2024 Mar;20(1):230126. doi: 10.1183/20734735.0126-2023. Epub 2024 Mar 12.
2
Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.美泊利单抗：240563，抗白细胞介素-5单克隆抗体 - 葛兰素史克公司，抗白细胞介素-5单克隆抗体 - 葛兰素史克公司，SB 240563
Drugs R D. 2008;9(2):125-30. doi: 10.2165/00126839-200809020-00006.
3
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.使用美泊利珠单抗治疗高嗜酸性粒细胞综合征患者。
N Engl J Med. 2008 Mar 20;358(12):1215-28. doi: 10.1056/NEJMoa070812. Epub 2008 Mar 16.
4
Steroid-sparing effect of mepolizumab in children with severe eosinophilic nonallergic asthma.美泊利珠单抗治疗儿童重度嗜酸性非变应性哮喘的激素节省效应。
Allergol Immunopathol (Madr). 2021 Sep 1;49(5):113-116. doi: 10.15586/aei.v49i5.466. eCollection 2021.
5
Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.高剂量美泊利珠单抗治疗嗜酸性粒细胞综合征的长期临床结局。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1518-1527.e5. doi: 10.1016/j.jaip.2018.04.033. Epub 2018 May 8.
6
Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.目前针对嗜酸性粒细胞增多综合征的管理策略，包括美泊利珠单抗。
Curr Med Res Opin. 2010 Aug;26(8):1933-46. doi: 10.1185/03007995.2010.493132.
7
A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma.抗白细胞介素 5 单克隆抗体美泊利珠单抗治疗高嗜酸性粒细胞综合征和哮喘的综述。
J Allergy Clin Immunol. 2010 Apr;125(4):803-13. doi: 10.1016/j.jaci.2009.11.048.
8
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.美泊利珠单抗作为变应性肉芽肿性血管炎患者的一种类固醇节省治疗选择。
J Allergy Clin Immunol. 2010 Jun;125(6):1336-43. doi: 10.1016/j.jaci.2010.03.028.
9
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.美泊利单抗用于治疗伴有痰液嗜酸性粒细胞增多的泼尼松依赖型哮喘。
N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.
10
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.美泊利珠单抗治疗嗜酸性粒细胞增多综合征的长期安全性。
J Allergy Clin Immunol. 2013 Feb;131(2):461-7.e1-5. doi: 10.1016/j.jaci.2012.07.055. Epub 2012 Oct 4.

引用本文的文献

1
Th2-High Severe Asthma with Hypereosinophilia in the Spectrum of Type 2 Inflammatory Diseases.2型炎症性疾病谱中伴有嗜酸性粒细胞增多的Th2高反应性重度哮喘
Int J Mol Sci. 2025 Jun 2;26(11):5342. doi: 10.3390/ijms26115342.

本文引用的文献

1
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC).欧洲支气管扩张症：欧洲支气管扩张症注册研究（EMBARC）中有关疾病特征的数据。
Lancet Respir Med. 2023 Jul;11(7):637-649. doi: 10.1016/S2213-2600(23)00093-0. Epub 2023 Apr 24.
2
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial.美泊利珠单抗治疗美国易恶化型嗜酸性粒细胞性哮喘城市儿童（MUPPITS-2）：一项随机、双盲、安慰剂对照、平行分组试验。
Lancet. 2022 Aug 13;400(10351):502-511. doi: 10.1016/S0140-6736(22)01198-9.
3
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study.
嗜酸粒细胞性支气管扩张症的特征：一项欧洲多队列研究。
Am J Respir Crit Care Med. 2022 Apr 15;205(8):894-902. doi: 10.1164/rccm.202108-1889OC.
4
Mapping Pulmonary and Systemic Inflammation in Preschool Aged Children With Cystic Fibrosis.绘制学龄前囊性纤维化儿童的肺部和全身炎症图谱。
Front Immunol. 2021 Oct 15;12:733217. doi: 10.3389/fimmu.2021.733217. eCollection 2021.
5
Structure and function of small airways in asthma patients revisited.哮喘患者小气道的结构和功能再探。
Eur Respir Rev. 2021 Jan 19;30(159). doi: 10.1183/16000617.0186-2020. Print 2021 Mar 31.
6
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.美泊利珠单抗治疗高嗜酸性粒细胞综合征的疗效和安全性：一项 III 期、随机、安慰剂对照试验。
J Allergy Clin Immunol. 2020 Dec;146(6):1397-1405. doi: 10.1016/j.jaci.2020.08.037. Epub 2020 Sep 18.
7
Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.儿童哮喘急性加重期治疗升级的干预措施：Cochrane系统评价综述
Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD012977. doi: 10.1002/14651858.CD012977.pub2.
8
Single-Cell Flow Cytometry Profiling of BAL in Children.儿童支气管肺泡灌洗液的单细胞流式细胞仪分析。
Am J Respir Cell Mol Biol. 2020 Aug;63(2):152-159. doi: 10.1165/rcmb.2019-0453MA.
9
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.孟鲁司特钠联合布地奈德治疗儿童哮喘的临床疗效观察
J Allergy Clin Immunol. 2019 Nov;144(5):1336-1342.e7. doi: 10.1016/j.jaci.2019.08.005. Epub 2019 Aug 16.
10
Bronchiectasis in children: diagnosis and treatment.儿童支气管扩张症：诊断与治疗。
Lancet. 2018 Sep 8;392(10150):866-879. doi: 10.1016/S0140-6736(18)31554-X.